Sun Pharmaceutical and Zydus Lifesciences shares could see pressure on Monday as both companies have issued limited recall for some pharmaceutical products in the US market.
KRChoksey Research has maintained its "BUY" recommendation for Aurobindo Pharma with a target price of Rs. 1,591, offering an upside potential of 33.5%.
Morningstar has reaffirmed its fair value estimate of $66 per share for Bristol-Myers Squibb (BMY), underscoring the company’s strong pipeline, wide economic moat, and solid financial position desp
Prabhudas Lilladher has reaffirmed its BUY recommendation on Cipla, driven by the company's strong financial performance and strategic growth initiatives.
Natco Pharma has achieved a significant milestone with the approval from the United States Food and Drug Administration (USFDA) for its generic version of Everolimus tablets for oral suspen
